indazoles has been researched along with ponatinib in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Adkins, J; Aldrich, J; Asmann, Y; Baker, A; Barr Fritcher, EG; Barrett, MT; Bhavsar, JD; Bible, KC; Block, M; Borad, MJ; Bryce, AH; Carpten, JD; Champion, MD; Cherni, I; Christoforides, A; Collins, JM; Condjella, RM; Craig, DW; Egan, JB; Fonseca, R; Han, H; Harris, P; Hunt, K; Izatt, T; Kipp, BR; Klee, EW; Kocher, JP; Kurdoglu, A; Lazaridis, KN; Liang, WS; Lobello, J; Mastrian, SD; McCullough, AE; McDonald, J; McWilliams, RR; Middha, S; Nair, AA; Nasser, S; Oliver, GR; Patel, MD; Phillips, L; Placek, P; Reiman, R; Schahl, K; Silva, AC; Stewart, AK; Von Hoff, D; Watanabe, AT; Young, SW | 1 |
| Bennett, KL; Bigenzahn, JW; Bruckner, M; Colinge, J; Fauster, A; Gridling, M; Huber, KV; Krautwald, S; Kubicek, S; Lardeau, CH; Linkermann, A; Parapatics, K; Rebsamen, M; Scorzoni, S; Stukalov, A; Superti-Furga, G | 1 |
| Chehab, F; Gunthorpe, M; Holmes, JP; Lasater, EA; Massi, ES; Politi, J; Sali, A; Shah, NP; Smith, CC; Stecula, A; Tan, SK | 1 |
| Fulda, S | 1 |
| Chen, L; Chen, X; Chen, Y; Chen, Z; Dai, S; Guo, M; Jiang, L; Li, G; Li, J; Li, M; Ma, Y; Min, X; Qu, L; Tan, S; Wu, D; Xu, G; Zhou, Z | 1 |
| Alessi, DR; Ganley, IG; Reith, AD; Singh, F; Tasegian, A | 1 |
1 review(s) available for indazoles and ponatinib
| Article | Year |
|---|---|
Repurposing anticancer drugs for targeting necroptosis.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Drug Repositioning; Humans; Imidazoles; Indazoles; Necrosis; Oximes; Pyridazines; Pyrimidines; Reperfusion Injury; Sorafenib; Sulfonamides; Systemic Inflammatory Response Syndrome; Vemurafenib | 2018 |
5 other study(ies) available for indazoles and ponatinib
| Article | Year |
|---|---|
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; ErbB Receptors; Erlotinib Hydrochloride; Genome, Human; Humans; Imidazoles; Indazoles; Molecular Targeted Therapy; Mutation; Prognosis; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Quinazolines; Receptor, Fibroblast Growth Factor, Type 2; Signal Transduction; Sulfonamides; Transcriptome | 2014 |
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Topics: 3T3 Cells; Animals; Apoptosis; Cell Line, Tumor; Fas-Associated Death Domain Protein; HEK293 Cells; HT29 Cells; Humans; Imidazoles; Indazoles; Jurkat Cells; L Cells; MAP Kinase Kinase Kinases; Mice; Necrosis; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Pyridazines; Pyrimidines; Receptor-Interacting Protein Serine-Threonine Kinases; Sulfonamides; Tumor Necrosis Factor-alpha | 2015 |
Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib.
Topics: Axitinib; Dasatinib; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Humans; Imidazoles; In Vitro Techniques; Indazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridazines | 2016 |
LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance.
Topics: Animals; Binding Sites; Cell Line; Drug Resistance, Neoplasm; Humans; Imidazoles; Indazoles; Mice; Mutation; Protein Kinase Inhibitors; Pyridazines; Receptors, Fibroblast Growth Factor | 2018 |
Impact of Type II LRRK2 inhibitors on signaling and mitophagy.
Topics: Animals; Benzamides; Fibroblasts; Gene Knockout Techniques; HEK293 Cells; HeLa Cells; Humans; Imidazoles; Indazoles; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mice; Mice, Inbred C57BL; Mitophagy; Neutrophils; Parkinson Disease; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridazines; Pyridines; Pyrimidines; Quinolines; Signal Transduction; Transfection | 2021 |